On Friday, April 21st, the U.S. Supreme Court announced its decision to maintain the legal status of mifepristone, the first of two drugs used in the RU-486 chemical abortion regimen. The 5th Circuit Court of Appeals had temporarily reinstated restrictions on the administration of mifepristone while the case was proceeding, but this decision paused those restrictions and leaves mifepristone widely available. The case now returns to the 5th Circuit Court of Appeals.
Alliance Defending Freedom Senior Counsel Erik Baptist said this about the decision: “As is common practice, the Supreme Court has decided to maintain the status quo that existed prior to our lawsuit while our challenge to the FDA’s illegal approval of chemical abortion drugs and its removal of critical safeguards for those drugs moves forward. Our case seeking to put women’s health above politics continues on an expedited basis in the lower courts. The FDA must answer for the damage it has caused to the health of countless women and girls and the rule of law by failing to study how dangerous the chemical abortion drug regimen is and unlawfully removing every meaningful safeguard, even allowing for mail-order abortions. We look forward to a final outcome in this case that will hold the FDA accountable.”
You can read more about the background for the case here.